Kanjinti Interactions
There are 191 drugs known to interact with Kanjinti (trastuzumab), along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 55 are major, and 136 are moderate.
- View all 191 medications that may interact with Kanjinti
- View Kanjinti alcohol/food interactions (1)
- View Kanjinti disease interactions (4)
Most frequently checked interactions
View interaction reports for Kanjinti (trastuzumab) and the medicines listed below.
- Aimovig (erenumab)
- albuterol
- Alpha-Lipoic-Acid-300 (alpha-lipoic acid)
- anastrozole
- Aromasin (exemestane)
- ashwaganda
- Augmentin (amoxicillin / clavulanate)
- azithromycin
- Azithromycin Dose Pack (azithromycin)
- B Complex 50 (multivitamin)
- bacopa
- Benadryl (diphenhydramine)
- bupropion
- calcium citrate
- Carafate (sucralfate)
- Centrum (multivitamin with minerals)
- Cheratussin AC (codeine / guaifenesin)
- Cipro (ciprofloxacin)
- Claritin (loratadine)
- clonazepam
- codeine / promethazine
- CoQ10 (ubiquinone)
- cyclobenzaprine
- DayQuil / NyQuil Severe Cold and Flu (acetaminophen / dextromethorphan / doxylamine / guaifenesin / phenylephrine)
- Dexilant (dexlansoprazole)
- Effexor XR (venlafaxine)
- Esgic (acetaminophen / butalbital / caffeine)
- eszopiclone
- letrozole
- trazodone
Kanjinti alcohol/food interactions
There is 1 alcohol/food interaction with Kanjinti (trastuzumab).
Kanjinti disease interactions
There are 4 disease interactions with Kanjinti (trastuzumab) which include:
Report options
QR code containing a link to this page
More about Kanjinti (trastuzumab)
- Kanjinti consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: HER2 inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.